Visual acuity a multifactorial metric

Article

Although image quality has a clear influence on visual acuity, it does not account for all the individual variability of other factors that must be involved including, measurement errors, or wavefront, optical or neural factors, Raymond Applegate said.

Although image quality has a clear influence on visual acuity, it does not account for all the individual variability of other factors that must be involved including, measurement errors, or wavefront, optical or neural factors, Raymond Applegate said.

Wavefront factors could include visual performance, while optical factors include issues like scatter or chromatic aberration. Neural factors include cone sampling, internal noise and cognitive issues, he remarked.

"In eyes with normal to excellent photopic high contrast (P HC) acuity, optical quality metrics increase in predictive value with increasing difficulty of the visual task," he said.

The more difficult the task, the more detailed and refined the ultimate visual acuity measurement will be. In the case of normal healthy eyes, high photopic stimuli makes P HC acuity insensitive to minor variations in wavefront error. As such, it's a less accurate metric.

For example, higher order aberrations (HOA) account for only 4% of the variance in photopic high contrast acuity. That means, only 4% of HOAs are detected. "In comparison, mesopic low contrast (M LC) acuity is eight times more sensitive than photopic high contrast acuity to the same variation in optical quality accounting for 37% of the variance in acuity."

Mesopic low contrast stimuli contain less redundant information and are therefore more sensitive to minor variations in image quality.

In a clinical environment the effect of minor variations on optical quality can be assessed with mesopic low contrast acuity, but not with photopic high contrast acuity, Dr Applegate noted.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.